Predicting prognosis and clinical efficacy of immune checkpoint blockade therapy via interferon-alpha response in muscle-invasive bladder cancer

Background: Immune checkpoint blockade (ICB) can prompt durable and robust responses in multiple cancers, involving muscle-invasive bladder cancer (MIBC). However, only a limited fraction of patients received clinical benefit. Clarifying the determinants of response and exploring corresponding predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Bohan, Zheng, Xin, Wang, Yicun, Hu, Xiaopeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110843/
https://www.ncbi.nlm.nih.gov/pubmed/37082269
http://dx.doi.org/10.3389/pore.2023.1611117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110843/
https://www.ncbi.nlm.nih.gov/pubmed/37082269
http://dx.doi.org/10.3389/pore.2023.1611117

Ejemplares similares